For one thing, high-profile approvals of Biogen’s Aduhelm and Eisai’s lecanemab ... a process innovation that was kicking along in very low gear until COVID-19 came along and launched it ...

Biogen and Eisai said the European Medicines Agency's Committee for Medicinal Products for Human Use has reaffirmed its recommended approval of their Alzheimer's drug Leqembi.

Biogen has arrived at a highly unusual solution to a dispute surrounding a patent for its blockbuster multiple sclerosis drug Tecfidera. It has agreed to pay Denmark’s Forward Pharma $1.25 ...

After hours: 7:49:09 p.m. EST ...

After hours: February 28 at 7:39:11 PM EST ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Pre-market: 5:14:55 am GMT-5 ...

UC Inclusive Credit Private Limited has sanctioned Term Loan of Rs. 8,00,00,000/- (Rupees Eight Crores Only) to Akme Fintrade (India) Limited. Shares of Akme Fintrade India Limited was last ...

Dividend announcements are not available.